Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction of Fibrosis Regression in Chronic Hepatitis B Infection (Entecavir)
2010-019884-12Phase 4Terminated
- Sponsor
- University Hospital RWTH Aachen
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of entecavir in hepatitis B (HBV) and hepatic fibrosis, sponsored by University Hospital RWTH Aachen. Primary endpoint: Change in non-invasive fibrosis markers after 12 months. Started Oct 2010; status: terminated.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)hepatic fibrosis
Beyond the preview
Go deeper on 2010-019884-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019884-12.